ARCHIVES

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

This article is from The Cancer Letter archive.

Vol. 39 No. 06 | February 7, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009